We are live on ! Find out more
MH

Mark Hillman Hillman Capital Management

AUM $138M
1-Year Est. Return 8.57%
 

Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.

This Fund
S&P 500
This Quarter Est. Return
-24.25%
1 Year Est. Return
+8.57%
3 Year Est. Return
+20.19%
5 Year Est. Return
+18.79%
10 Year Est. Return
AUM
$104M
AUM Growth
-$36.7M
Cap. Flow
+$3.98M
Cap. Flow %
3.82%
Top 10 Hldgs %
43.25%
Holding
53
New
3
Increased
20
Reduced
12
Closed
17

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$3.12M
2
GIS icon
General Mills
GIS
+$3.12M
3
MDT icon
Medtronic
MDT
+$2.48M
4
GE icon
GE Aerospace
GE
+$1.66M
5
LRCX icon
Lam Research
LRCX
+$1.45M

Sector Composition

Rank Sector Weight
1 Healthcare 26.36%
2 Consumer Discretionary 12.34%
3 Consumer Staples 11.99%
4 Communication Services 8.77%
5 Financials 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
51
Microchip Technology
MCHP
$41.3B
-4,410
Closed -$231K
SCHW
52
Charles Schwab
SCHW
$194B
-4,647
Closed -$221K
SPY icon
53
State Street SPDR S&P 500 ETF Trust
SPY
$809B
-1,350
Closed -$435K

Similar funds

Mark Hillman's Q1 2020 Portfolio in Review

As of Q1 2020, Mark Hillman held 53 positions worth $104M, down 26% from $141M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Mark Hillman deployed $3.98M of net new capital in Q1 2020, opening 3 new positions and adding to 20 existing holdings. Its largest new stake was Raytheon Company: 21,900 shares worth $2.87M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Medtronic, an estimated $2.48M trimmed.

  • Mark Hillman's largest Q1 2020 buy was Raytheon Company: 21,900 shares worth $2.87M.
  • Mark Hillman added most to AB InBev in Q1 2020, an estimated $2.07M increase.
  • Mark Hillman's biggest Q1 2020 reduction was Medtronic, cutting an estimated $2.48M.
  • Mark Hillman fully exited IBM in Q1 2020, selling an estimated $3.12M.
  • Mark Hillman's ten largest holdings make up 43% of its $104M portfolio in Q1 2020.
  • Mark Hillman opened 3 new positions and closed 17 in Q1 2020.
  • Mark Hillman's portfolio value fell 26% quarter-over-quarter to $104M.

Based on Hillman Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.